EVH + Mannitol for Cough Variant Asthma
Recruiting in Palo Alto (17 mi)
Overseen byM. Diane Lougheed, MD, MSc
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Phase 4
Recruiting
Sponsor: Dr. Diane Lougheed
No Placebo Group
Prior Safety Data
Trial Summary
What is the purpose of this trial?The objectives of this study are to determine the sensory-mechanical responses to Eucapneic Voluntary Hyperventilation (EVH) and Mannitol in individuals with cough variant asthma (CVA) and methacholine-induced cough with normal airway sensitivity (COUGH) and compare these responses to a control group of healthy individuals without asthma or chronic cough.
We hypothesize:
1. EVH and Mannitol cause dyspnea, cough, small airway obstruction with resultant dynamic hyperinflation, gas trapping and autoPEEP in individuals with CVA and COUGH, but not healthy controls.
2. The sensory-mechanical responses to both hyperosmolar challenges (EVH and Mannitol) are comparable within groups (CVA, COUGH and healthy controls).
Eligibility Criteria
This trial is for adults aged 18-65 with cough variant asthma or chronic cough due to methacholine-induced cough but normal airway sensitivity. It's also open to healthy individuals without a history of asthma or chronic cough. People can't join if they've had a recent exacerbation, can't do proper lung function tests, have conditions that make the methacholine test unsafe, or have smoked heavily.Inclusion Criteria
I have had a chronic cough for over 8 weeks and it improved with asthma treatment.
I am between 18 and 65 years old and have had a stroke or cough caused by methacholine with normal airway sensitivity.
I have had a cough for over 8 weeks and passed a specific breathing test.
+1 more
Exclusion Criteria
I cannot perform a lung function test properly.
I've had a health issue in the last month that required changing my medication or a hospital visit.
You have medical reasons that make it unsafe for you to do the methacholine challenge test.
+1 more
Participant Groups
The study aims to understand how people with certain types of coughs and healthy controls respond to two different stimuli: breathing exercises (EVH) and Mannitol inhalation. Researchers want to see if these cause symptoms like shortness of breath and whether there are differences in lung mechanics between groups.
3Treatment groups
Experimental Treatment
Group I: Methacholine-induced coughExperimental Treatment3 Interventions
Individuals with chronic cough and negative methacholine challenge
Group II: Cough Variant AsthmaExperimental Treatment3 Interventions
Individuals diagnosed with Cough variant asthma
Group III: ControlExperimental Treatment3 Interventions
Individuals with no history of asthma or chronic cough
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
Kingston Health Sciences CentreKingston, Canada
Loading ...
Who Is Running the Clinical Trial?
Dr. Diane LougheedLead Sponsor
Dr. Diane LougheedLead Sponsor